Shaklee Product Catalogue 2018 - Canada/English - 9
THE SHAKLEE DIFFERENCE™
"The Shaklee population was only one
third as likely to have telomeres in the
bottom quartile based on other studies
that examined short telomeres and their
relationship to a long, healthy life."
DR. ELIZABETH BLACKBURN
SHAKLEE SCIENTIFIC BOARD ADVISOR
2009 NOBEL PRIZE WINNER IN MEDICINE
Dr. Elizabeth Blackburn, a Shaklee Scientific Board
advisor, was awarded the 2009 Nobel Prize in
Medicine for the discovery of telomerase, an enzyme
that lengthens telomeres and protects chromosomes.
Shaklee conducted the preliminary Telomere Study,
which compared people using multiple Shaklee
supplements for at least five years with healthy nonsmokers living in the San Francisco Bay Area.
This clinical study showed that the Shaklee longterm supplement users had a 40% lower rate of
telomere shortening across the adult age range
compared with the healthy control group.†
SHAKLEE USERS HAD LONGER TELOMERES
A STATISTICAL ANALYSIS BASED ON THE PRELIMINARY
CLINICAL STUDY PROJECTS THAT AN 80-YEAR-OLD
SHAKLEE USER WOULD HAVE THE SAME TELOMERE
LENGTH AS A 41-YEAR-OLD NON-USER.‡
Telomeres are protective caps of repetitive
DNA at the end of chromosomes. Our
telomeres gradually become shorter, and
telomere length is thought to be a marker
of overall health.
†In a preliminary clinical study, Shaklee long-term users who took Vivix® (see page 24) and other Shaklee supplements had a 40% lower rate of telomere shortening across the adult age
range compared with a healthy control group.
‡Harley CB, et al. Cross-sectional analysis of telomere length in people 33-80 years of age: effects of dietary supplementation. JACN. 55th Annual Conference. 2014 Oct; 33(5): 414.